Esphera SynBio is a synthetic biology company specializing in the development of nanomedicine vaccines for cancer and infectious diseases. Utilizing a breakthrough platform of proprietary transgenes, the company produces engineered exosomes in vivo, which serve as innovative therapeutic solutions in the field of vaccine development.
Leadership & Board
Current Number of Employees10
Current LinkedIn Followers606
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$2M
Total Amount Raised$2M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$2M
Latest Funding Amount$2M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Esphera SynBio had 10 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Esphera SynBio had 606 followers as of April 6, 2026. The number of followers increased by 10 (1.68%) week-over-week.
606Latest Followers Count
10(1.68%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.